Tissue plasminogen activator and glial function

GLIA

Volumn 49, Issue 2, 2005, Pages 177-183

  Gravanis, Iordanis ^a   Tsirka, Stella E ^a  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Astrocytes; Glial cells; Microglial cells; Schwann cells; Therapeutic targets; tPA

Indexed keywords

SCLEROPROTEIN; SERINE PROTEINASE; TISSUE PLASMINOGEN ACTIVATOR;

ASTROCYTE; BRAIN; BRAIN FUNCTION; CELL FUNCTION; GLIA; MICROGLIA; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SCHWANN CELL; STROKE; THROMBOSIS; TISSUE REGENERATION;

ANIMALS; ASTROCYTES; BRAIN; EXTRACELLULAR MATRIX; GLIOSIS; HUMANS; MICROGLIA; NEUROGLIA; NEURONAL PLASTICITY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 13244274999     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/glia.20115     Document Type: Review

References (73)

1. Ahn MY, Zhang ZG, Tsang W, Chopp M. 1999. Endogenous plasminogen activator expression after embolic focal cerebral ischemia in mice. Brain Res 837:169-176.
2. Akassoglou K, Kombrinck KW, Degen JL, Strickland S. 2000. Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury. J Cell Biol 149:1157-1166.
3. Akassoglou K, Yu WM, Akpinar P, Strickland S. 2002. Fibrin inhibits peripheral nerve remyelination by regulating Schwann cell differentiation. Neuron 33:861-875.
4. Akassoglou K, Akpinar P, Murray S, Strickland S. 2003. Fibrin is a regulator of Schwann cell migration after sciatic nerve injury in mice. Neurosci Lett 338:185-188.
5. Baranes D, Lederfein D, Huang YY, Chen M, Bailey CH, Kandel ER. 1998. Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway. Neuron 21:813-825.
6. Benchenane K, Lopez-Atalaya JP, Fernandez-Monreal M, Touzani O, Vivien D. 2004. Equivocal roles of tissue-type plasminogen activator in stroke-induced injury. Trends Neurosci 27:155-160.
7. Blasi F, Ciarrocchi A, Luddi A, Strazza M, Riccio M, Santi S, Arcone R, Pietropaolo C, D'Angelo R, Costantino-Ceccarini E, Melli M. 2002. Stage-specific gene expression in early differentiating oligodendrocytes. Glia 39:114-123.
8. Bu G, Williams S, Strickland DK, Schwartz AL. 1992. Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator. Proc Natl Acad Sci USA 89:7427-7431.
9. Carroll PM, Tsirka SE, Richards WG, Frohman MA, Strickland S. 1994. The mouse tissue plasminogen activator gene 5′ flanking region directs appropriate expression in development and a seizure-enhanced response in the CNS. Development 120:3173-3183.
10. Chang DI, Hosomi N, Lucero J, Heo JH, Abumiya T, Mazar AP, del Zoppo GJ. 2003. Activation systems for latent matrix metalloproteinase-2 are upregulated immediately after focal cerebral ischemia. J Cereb Blood Flow Metab 23:1408-1419.
11. Chen ZL, Strickland S. 1997. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 91:917-925.
12. Cinelli P, Madani R, Tsuzuki N, Vallet P, Arras M, Zhao CN, Osterwalder T, Rulicke T, Sonderegger P. 2001. Neuroserpin, a neuroprotective factor in focal ischemic stroke. Mol Cell Neurosci 5:443-57.
13. Collen D. 1999. The plasminogen (fibrinolytic) system. Thromb Haemost 82:259-270.
14. Davies BJ, Pickard BS, Steel M, Morris RG, Lathe R. 1998. Serine proteases in rodent hippocampus. J Biol Chem 273:23004-23011.
15. Docagne F, Nicole O, Marti HH, MacKenzie ET, Buisson A, Vivien D. 1999. Transforming growth factor-beta1 as a regulator of the serpins/t-PA axis in cerebral ischemia. FASEB J 13:1315-1324.
16. Docagne F, Nicole O, Gabriel C, Fernandez-Monreal M, Lesne S, Ali C, Plawinski L, Carmeliet P, MacKenzie ET, Buisson A, Vivien D. 2002. Smad3-dependent induction of plasminogen activator ihhibitor-1 in astrocytes mediates neuroprotective activity of transforming growth factor-beta 1 against NMDA-induced necrosis. Mol Cell Neurosci 21:634-644.
17. Endo A, Nagai N, Urano T, Takada Y, Hashimoto K, Takada A. 1999. Proteolysis of neuronal cell adhesion molecule by the tissue plasminogen activator-plasmin system after kainate injection in the mouse hippocampus. Neurosci Res 33:1-8.
18. Fernandez-Monreal M, Lopez-Atayala JP, Benchenane K, Leveille F, Cacquevel M, Plawinski L, MacKenzie ET, Bu G, Buisson A., Vivien D. 2004. Is tissue-type plasminogen activator a neuromodulator? Mol Cell Neurosci 25:594-601.
19. Fisher M and Francis R. 1990. Altered coagulation in cerebral ischemia. Platelet, thrombin and plasmin activity. Arch Neurol 47:1075-1079.
20. Frey U, Muller M, Kuhl D. 1996. A different form of long-lasting potentiation revealed in tissue plasminogen activator mutant mice. J Neurosci 16:2057-2063.
21. Gabriel C, AIi C, Lesne S, Fernandez-Monreal M, Docagne F, Plawinski L, MacKenzie ET, Buisson A, Vivien D. 2003. Transforming growth factor alpha-induced expression of type 1 plasminogen activator inhibitor in astrocytes rescues neurons from excitotoxicity. FASEB J 17:277-279.
22. Gingrich MB, Traynelis SF. 2000. Serine proteases and brain damage - is there a link? Trends Neurosci 23:399-407.
23. Hastings GA, Coleman TA, Haudenschild CC, Stefansson S, Smith EP, Barthlow R, Cherry S, Sandkvist M, Lawrence DA. 1997. Neuroserpin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons. Implications for the regulation of motor learning and neuronal survival. J Biol Chem 272:33062-33067.
24. Hino H, Akiyama H, Iseki E, Kato M, Kondo H, Ikeda K, Kosaka K. 2001. Immunohistochernical localization of plasminogen activator inhibitor-1 in rat and human brain tissues. Neurosci Lett 297:105-108.
25. Huang YY, Bach ME, Lipp HP, Zhuo M, Wolfer DP, Hawkins RD, Schoonjans L, Kandel ER, Godfraind JM, Mulligan, Collen D, Carmeliet P. 1996. Mice lacking the gene encoding tissue-type plasminogen activator show a selective interference with late-phase long-term potentiation in both Schaffer collateral and mossy fiber pathways. Proc Natl Acad Sci USA 93:8699-8704.
26. Indyk JA, Chen ZL, Tsirka SE, Strickland S. 2003. Laminin chain expression suggests that laminin-10 is a major isoform in the mouse hippocampus and is degraded by the tissue plasminogen activator/ plasmin protease cascade during excitotoxic injury. Neuroscience 116:359-371.
27. Kim YH, Park JH, Hong SH, Koh JY. 1999. Nonproteolytic neuroprotection by human recombinant tissue plasminogen activator. Science 284:647-650.
28. Kirchhoff F, Dringen R, Giaume C. 2001. Pathways of neuron-astrocyte interactions and their possible role in neuroprotection. Eur Arch Psychiatry Clin Neurosci 251:159-169.
29. Kreutzberg GW. 1996. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19:312-318.
30. Krystosek A, Seeds NW. 1981. Plasminogen activator release at the neuronal growth cone. Science 213:1532-1534.
31. Krystosek A, Seeds NW. 1984. Peripheral neurons and Schwann cells secrete plasminogen activator. J Cell Biol 98:773-776.
32. Ling Q, Jacovina AT, Deora A, Febbraio M, Simantov R, Silverstein RL, Hempstead B, Mark WH and Hajjar KA. 2004. Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo. J Clin Invest 113:38-48.
33. Madani R, Hulo S, Toni N, Madani H, Steimer T, Muller D, Vassalli JD. 1999. Enhanced hippocampal long-term potentiation and learning by increased neuronal expression of tissue-type plasminogen activator in transgenic mice. EMBO J 18:3007-3012.
34. Margaglione M, Di Minno G, Grandone E, Vecchione G, Celentano E, Cappucci G, Grilli M, Simone P, Panico S, Mancini M. 1994. Abnormally high circulation levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of ischemic stroke. Arterioscler Thromb 14:1741-1745.
35. Masos T and Miskin R. 1997. mRNAs encoding urokinase-type plasminogen activator and plasminogen activator inhibitor-1 are elevated in the mouse brain following kainate-mediated excitation. Brain Res Mol Brain Res 47:157-169.
36. Melchor JP, Pawlak R, Strickland S. 2003. The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-beta (Abeta) degradation and inhibits Abeta-induced neurodegeneration. J Neurosci 23:8867-8871.
37. Mulligan LP, Rosenblatt DE, Toms R, Johnson D. 1991. Protease nexin-1 activity in cultured Schwann cells. Neurosci Lett 128:42-46.
38. Nagai N, De Mol M, Lijnen HR, Carmeliet P, Collen D. 1999. Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice. Circulation 99:2440-2444.
39. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. 1995. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581-1587.
40. Nicole O, Docagne F, Ali C, Margaill I, Carmeliet P, MacKenzie ET, Vivien D, Buisson A. 2001. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med 7:59-64.
41. Noorbakhsh F, Vergnolle N, Hollenberg MD, Power C. 2003. Proteinase-activated receptors in the nervous system. Nat Rev Neurosci 4:981-990.
42. Osterwalder T, Contartese J, Stoeckli ET, Kuhn TB, Sonderegger P. 1996. Neuroserpin, an axonally secreted serine protease inhibitor. EMBO J 15:2944-2953.
43. Pittman RN, Ivins JK, Buettner HM. 1989. Neuronal plasminogen activators: cell surface binding sites and involvement in neurite outgrowth. J Neurosci 9:4269-4286.
44. Qian Z, Gilbert ME, Colicos MA, Kandel ER, Kuhl D. 1993. Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation. Nature 361:453-457.
45. Rabchevsky AG, Streit WJ. 1997. Grafting of cultured microglial cells into the lesioned spinal cord of adult rats enhances neurite outgrowth. J Neurosci Res 47:34-48.
46. Reinhard E, Suidan HS, Pavlik A, Monard D. 1994. Glia-derived nexin/protease nexin-1 is expressed by a subset of neurons in the rat brain. J Neurosci Res 37:256-270.
47. Register B, Leprince P, Pettmann B, Labourdette G, Sensenbrenner M, Moonen G. 1988. Brain basic fibroblast growth factor stimulates the release of plasminogen activators by newborn rat cultured astroglial cells. Neurosci Lett 91:321-326.
48. Rogove AD, Tsirka SE. 1997. Neurotoxic responses by microglia elicited by excitotoxic injury in the mouse hippocampus. Curr Biol 8:19-25.
49. Rogove AD, Siao C, Keyt B, Strickland S, Tsirka SE. 1999. Activation of microglia reveals a non-proteolytic cytokine function for tissue plasminogen activator in the central nervous system. J Cell Sci 112:4007-4016.
50. Rosenblatt DE, Cotman CW, Nieto-Sampedro M, Rowe JW, Knauer DJ. 1987. Identification of a protease inhibitor produced by astrocytes that is structurally and functionally homologous to human protease nexin-I. Brain Res 415:40-48.
51. Sallés FJ and Strickland S. 2002. Localization and regulation of the tissue plasminogen activator-plasmin system in the hippocampus. J Neurosci 22:2125-2134.
52. Sappino AP, Madani R, Huarte J, Belin D, Kiss JZ, Wohlwend A, Vassalli JD. 1993. Extracellular proteolysis in the adult murine brain. J Clin Invest 92:679-685.
53. Seeds NW, Williams BL, Bickford PC. 1995. Tissue plasminogen activator induction in Purkinje neurons after cerebellar motor learning. Science 270:1992-1994.
54. Seeds NW, Friedman G, Hayden S, Thewke D, Haffke S, McGuire P, Krystosek A. 1996. Plasminogen activators and their interaction with the extracellular matrix in neural development, plasticity and regeneration. Semin Neurosci 8:405-412.
55. Siao CJ, Tsirka SE. 2002. Tissue plasminogen activator mediates microglial activation via its finger domain through annexin II. J Neurosci 22:3352-3358.
56. Siao CJ, Fernandez SR, Tsirka SE. 2003 Cell type-specific roles for tissue plasminogen activator released by neurons or microglia after excitotoxic injury. J Neurosci 23:3234-3242.
57. Siconolfi LB, Seeds NW. 2001a. Induction of the plasminogen activator system accompanies peripheral nerve regeneration after sciatic nerve crush. J Neurosci 21:4336-47.
58. Siconolfi LB, Seeds NW. 2001b. Mice lacking tPA, uPA, or plasminogen genes showed delayed functional recovery after sciatic nerve crush. J Neurosci 21:4348-55.
59. Siddiq M, Tsirka SE. 2004. Modulation of zinc toxicity by tissue plasminogen activator. Mol Cell Neurosci 25:162-171.
60. Simpson CS, Johnston HM, Morris BJ. 1994. Neuronal expression of protease-nexin 1 mRNA in rat brain. Neurosci Lett 170:286-290.
61. Sinnreich M, Meins M, Niclou SP, Suidan HS, Monard D. 2004. Prothrombin overexpressed in post-natal neurones requires blood factors for activation in the mouse brain. J Neurochem 88:1380-1388.
62. Streit WJ, Walter SA, Pennell NA. 1999. Reactive microgliosis. Prog Neurobiol 57:563-581.
63. Tsirka SE, Gualandris A, Amaral DG, Strickland S. 1995. Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 377:340-344.
64. Tsirka SE, Rogove AD, Strickland S. 1996. Neuronal cell death and tPA. Nature 384:123-124.
65. Tsirka SE, Rogove AD, Bugge TH, Degen JL, Strickland S. 1997. An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J Neurosci 17:543-552.
66. Wang YF, Tsirka SE, Strickland S, Stieg PE, Soriano SG, Lipton SA. 1998. Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat Med 4:228-231.
67. Wu YP, Siao CJ, Lu W, Sung TC, Frohman MA, Milev P, Bugge TH, Degen JL, Levine JM, Margolis RU, Tsirka SE. 2000. The tissue plasminogen activator (tPA)/plasmin extracellular proteolytic system regulates seizure-induced hippocampal mossy fiber outgrowth through a proteoglycan substrate. J Cell Biol 148:1295-1304.
68. Xi G, Reiser G, Keep RF. 2003. The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective? J Neurochem 84:3-9.
69. Yepes M, Sandkvist M, Wong MK, Coleman TA, Smith E, Cohan SL, Lawrence DA. 2000. Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis. Blood 96:569-576.
70. Yepes M, Sandkvist M, Moore EG, Bugge TH, Strickland DK, Lawrence DA. 2003. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J Clin Invest 112:1533-1540.
71. Zhang Z, Zhang L, Yepes M, Jiang Q, Li Q, Arniego P, Coleman TA, Lawrence DA, Chopp M. 2002. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke. Circulation 106:740-745.
72. Zhang ZG, Chopp M, Goussev A, Lu D, Morris D, Tsang W, Powers C, Ho KL. 1999. Cerebral microvascular obstruction by fibrin is associated with upregulation of PAI-1 acutely after onset of focal embolic ischemia in rats. J Neurosci 19:10898-10907.
73. Zhao G, Reynolds JN, Flavin MP. 2003. Temporal profile of tissue plasminogen activator (tPA) and inhibitor expression after transient focal cerebral ischemia. NeuroReport 14:1689-1692.